Case File №
#VI-2026-0478
Welon Peptide Solutions
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
42 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | D Poor | 5 | 6.4 | 3.3 | 7.8 | 23 Nov 2025 |
| 5-amino-1MQ | X N/A | 1 | 6.4 | 6.4 | 6.4 | 8 Jul 2025 |
| Adipotide | X N/A | 1 | 6.8 | 6.8 | 6.8 | 13 Jun 2025 |
| AHK-CU | X N/A | 1 | 5.9 | 5.9 | 5.9 | 2 Jul 2025 |
| AICAR | X N/A | 1 | 6.4 | 6.4 | 6.4 | 13 Feb 2025 |
| Alprostadil | X N/A | 1 | 5.4 | 5.4 | 5.4 | 13 Feb 2025 |
| Andarine S4 | X N/A | 1 | 7.9 | 7.9 | 7.9 | 20 Jun 2025 |
| Botulinum toxin | X N/A | 1 | 5.4 | 5.4 | 5.4 | 13 Feb 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 4.0 | 4.0 | 4.0 | 7 May 2025 |
| CJC-1295 With DAC | X N/A | 1 | 5.6 | 5.6 | 5.6 | 8 Jul 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 7.5 | 7.5 | 7.5 | 3 Jul 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 6.4 | 6.4 | 6.4 | 3 Jul 2025 |
| Crystagen | X N/A | 1 | 6.9 | 6.9 | 6.9 | 7 May 2025 |
| Dianabol Oil | X N/A | 1 | 7.0 | 7.0 | 7.0 | 28 Mar 2025 |
| Dutasteride | X N/A | 1 | 4.5 | 4.5 | 4.5 | 16 Mar 2025 |
| GHRP-6 Acetate | X N/A | 1 | 8.3 | 8.3 | 8.3 | 13 Feb 2025 |
| Halotestin (Fluoxymesterone) | X N/A | 1 | 7.4 | 7.4 | 7.4 | 2 Apr 2025 |
| HMG | X N/A | 1 | 7.5 | 7.5 | 7.5 | 21 May 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 5.8 | 5.8 | 5.8 | 21 May 2025 |
| Lipo-B 216mg | X N/A | 1 | 6.8 | 6.8 | 6.8 | 28 Mar 2025 |
| Lipo-C FOCUS 425mg | X N/A | 1 | 5.3 | 5.3 | 5.3 | 27 Feb 2025 |
| Liraglutide | X N/A | 1 | 5.1 | 5.1 | 5.1 | 20 Jun 2025 |
| Livagen | X N/A | 1 | 6.0 | 6.0 | 6.0 | 11 Jun 2025 |
| MGF | X N/A | 1 | 6.8 | 6.8 | 6.8 | 6 May 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 4.0 | 3.6 | 3.6 | 3 Jun 2025 |
| NandroMix 300 | X N/A | 1 | 8.2 | 8.2 | 8.2 | 17 Dec 2024 |
| Oxytocin Acetate | X N/A | 1 | 6.1 | 6.1 | 6.1 | 2 Apr 2025 |
| PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | X N/A | 1 | 9.0 | 9.0 | 9.0 | 9 Jun 2025 |
| Primobolan Oral (Methenolone Acetate) | X N/A | 1 | 5.4 | 5.4 | 5.4 | 13 Jun 2025 |
| Proviron (Mesterolone) | X N/A | 1 | 5.8 | 5.8 | 5.8 | 2 Jul 2025 |
| PTD-DBM | X N/A | 1 | 4.0 | 3.9 | 3.9 | 11 Jun 2025 |
| RIPEX 225 (TRA/Mast P/Test P) | X N/A | 1 | 4.0 | 3.8 | 3.8 | 14 Jan 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 7.7 | 7.7 | 7.7 | 16 Mar 2025 |
| Semax | X N/A | 1 | 8.9 | 8.9 | 8.9 | 3 Jul 2025 |
| SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) | X N/A | 1 | 5.1 | 5.1 | 5.1 | 8 Jul 2025 |
| SR9009 | X N/A | 1 | 6.6 | 6.6 | 6.6 | 3 Jun 2025 |
| Superdrol | X N/A | 1 | 5.1 | 5.1 | 5.1 | 3 Jun 2025 |
| Sustanon 250 | X N/A | 1 | 7.5 | 7.5 | 7.5 | 3 Jun 2025 |
| T4 (Levothyroxine) | X N/A | 1 | 7.6 | 7.6 | 7.6 | 16 Mar 2025 |
| Test Suspension | X N/A | 1 | 7.6 | 7.6 | 7.6 | 27 Feb 2025 |
| Trenbolone Enanthate | X N/A | 1 | 7.4 | 7.4 | 7.4 | 9 Jun 2025 |
| Vilon | X N/A | 1 | 5.8 | 5.8 | 5.8 | 2 Jul 2025 |
Exhibit II
Evidence Log
46 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.9 A | 5mg | 4.5mg | -11.0% | 96.11% | 7uprfy | Lab B | Community |
| 24 May 2026 | MGF | 6.8 A | 15mg | 17.5mg | +16.6% | 98.14% | 19kw9m | Lab C | Public |
| 24 May 2026 | Vilon | 6.8 A | 30mg | 29.5mg | -1.8% | 98.99% | davgf5 | Lab E | Community |
| 24 May 2026 | AICAR | 5.1 B | 30mg | 26.9mg | -10.5% | 99.76% | n4min0 | Lab D | Public |
| 24 May 2026 | Andarine S4 | 8.3 A | 25mg | 22.5mg | -10.0% | 99.48% | wbxfzn | Lab D | Public |
| 24 May 2026 | Lipo-C FOCUS 425mg | 4.6 C | 100mg/ml | 111.8mg/ml | +11.8% | 99.36% | e4qk1r | Lab G | Community |
| 24 May 2026 | Primobolan Oral (Methenolone Acetate) | 4.6 C | 25mg | 21.4mg | -14.3% | 99.61% | j5zc1w | Lab F | Public |
| 24 May 2026 | Liraglutide | 4.2 C | 2mg | 1.8mg | -8.5% | 98.67% | gipmwp | Lab E | Public |
| 24 May 2026 | Semax | 8.9 A | 20mg | 23.3mg | +16.3% | 99.05% | okjms9 | Lab F | Public |
| 24 May 2026 | SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) | 6.3 A | 250mg/ml | 282.6mg/ml | +13.0% | 99.08% | q95ao0 | Lab D | Community |
| 24 May 2026 | T4 (Levothyroxine) | 7.4 A | 20mg | 17.8mg | -11.1% | 99.58% | 4ty6qd | Lab D | Public |
| 23 May 2026 | Superdrol | 5.5 B | 10mg | 10.5mg | +5.2% | 96.03% | fq8ozc | Lab D | Community |
| 23 May 2026 | AHK-CU | 6.7 A | 30mg | 33.6mg | +11.9% | 95.75% | iggdoe | Lab A | Public |
| 22 May 2026 | Retatrutide | 7.8 A | 10mg | 9.74mg | -2.6% | 99.84% | low | No Label / Silver Crimp / Green Cap | Lab E |
| 21 May 2026 | Retatrutide | 7.0 A | 10mg | 9.22mg | -7.8% | 99.88% | n/a | No Label / Silver Crimp / Yellow Cap | Lab E |
| 21 May 2026 | RIPEX 225 (TRA/Mast P/Test P) | 4.3 C | 100mg/ml | 100.5mg/ml | +0.5% | 98.09% | di8ez0 | Lab A | Community |
| 19 May 2026 | BPC157 10mg + TB500 10mg Blend | 4.0 C | 50mg | 51.8mg | +3.5% | 97.06% | kq19dn | Lab G | Public |
| 17 May 2026 | Retatrutide | 7.0 A | 10mg | 10mg | 99.50% | n/a | No Label / Silver Crimp / Clear Blue Cap | Lab G | |
| 17 May 2026 | Retatrutide | 6.8 B | 10mg | 10.3mg | +3.0% | 99.40% | n/a | No Label / Silver Crimp / Clear Blue Cap | Lab G |
| 17 May 2026 | Adipotide | 8.2 A | 30mg | 35.1mg | +16.9% | 95.49% | q7v46j | Lab B | Public |
| 29 Jan 2026 | Dianabol Oil | 6.6 A | 100mg/ml | 116.8mg/ml | +16.8% | 98.27% | 2d1lom | Lab F | Public |
| 29 Jan 2026 | PTD-DBM | 4.1 C | 50mg | 55.2mg | +10.5% | 99.34% | tjxvb5 | Lab C | Community |
| 26 Jan 2026 | Alprostadil | 4.0 C | 5mg | 4.8mg | -4.0% | 95.81% | k3mtp1 | Lab B | Public |
| 26 Jan 2026 | Dutasteride | 4.0 C | 50mg | 49.0mg | -2.0% | 95.48% | s2hhjp | Lab E | Public |
| 9 Jan 2026 | CJC-1295 With DAC | 4.8 C | 30mg | 31.1mg | +3.8% | 97.78% | jg3qsh | Lab F | Community |
| 9 Jan 2026 | Crystagen | 6.7 A | 20mg | 21.0mg | +5.2% | 96.02% | uv5eqt | Lab F | Public |
| 7 Jan 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 7.2 A | 50mg | 52.3mg | +4.7% | 97.87% | tgf1ts | Lab F | Community |
| 7 Jan 2026 | NandroMix 300 | 5.8 B | 300mg/ml | 335.4mg/ml | +11.8% | 96.86% | 41zyjj | Lab D | Public |
| 6 Jan 2026 | 5-amino-1MQ | 6.2 A | 5mg | 5.3mg | +5.9% | 98.15% | d04vhp | Lab B | Community |
| 29 Dec 2025 | GHRP-6 Acetate | 8.1 A | 20mg | 22.9mg | +14.5% | 97.08% | 2mji3b | Lab B | Community |
| 29 Dec 2025 | Trenbolone Enanthate | 6.4 A | 300mg/ml | 338.7mg/ml | +12.9% | 97.02% | mpbpgb | Lab D | Community |
| 12 Dec 2025 | Botulinum toxin | 5.1 B | 50mg | 48.5mg | -3.1% | 97.99% | d6gud5 | Lab C | Public |
| 12 Dec 2025 | N-Acetyl Epitalon Amidate | 4.3 C | 30mg | 26.4mg | -12.1% | 95.47% | kwsrp7 | Lab E | Community |
| 12 Dec 2025 | Proviron (Mesterolone) | 6.6 A | 10mg | 10.4mg | +3.7% | 95.38% | uaqjjw | Lab D | Public |
| 5 Dec 2025 | Lipo-B 216mg | 7.7 A | 100mg/ml | 112.5mg/ml | +12.5% | 99.11% | 6xqpyp | Lab D | Public |
| 5 Dec 2025 | Livagen | 4.6 C | 5mg | 4.9mg | -1.4% | 98.08% | 6k1uad | Lab G | Public |
| 5 Dec 2025 | SR9009 | 6.1 A | 25mg | 23.1mg | -7.5% | 97.00% | w59oqt | Lab B | Public |
| 23 Nov 2025 | Retatrutide | 3.3 E | 15mg | 21.7mg | +44.7% | 99.30% | n/a | White Label / Copper Crimp / Clear Cap | Lab G |
| 14 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.0 C | 50mg | 62.5mg | +24.9% | 99.22% | mx0s49 | Lab B | Community |
| 14 Nov 2025 | Test Suspension | 9.0 A | 200mg/ml | 200.6mg/ml | +0.3% | 97.31% | 23j87i | Lab E | Public |
| 5 Nov 2025 | Sustanon 250 | 7.3 A | 250mg/ml | 297.5mg/ml | +19.0% | 98.86% | e6dnzk | Lab F | Public |
| 4 Nov 2025 | Oxytocin Acetate | 4.5 C | 15mg | 14.8mg | -1.6% | 95.03% | nzq3fo | Lab B | Public |
| 4 Nov 2025 | Selank 10mg + Semax 10mg Blend | 8.2 A | 5mg | 5.6mg | +12.7% | 97.02% | 1cpmmy | Lab G | Community |
| 9 Oct 2025 | HMG | 8.4 A | 50mg | 49.7mg | -0.6% | 95.34% | 3ug6xp | Lab D | Community |
| 9 Oct 2025 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 9.9 A | 100g | 122.3g | +22.3% | 95.93% | dp81ay | Lab A | Community |
| 3 Oct 2025 | Halotestin (Fluoxymesterone) | 5.5 B | 10mg | 11.7mg | +17.1% | 96.66% | cqznqu | Lab C | Public |
— END OF EVIDENCE LOG —